CHM - ORTNational Target
General
Mali
D'ici à 2030, tous les instruments juridiques et institutionnels de Biosécurité sont opérationnels en vue d'une meilleure protection de la santé humaine, animale et végétale contre les effets néfastes des produits issus des Biotechnologies modernes.
FRrelecture des textes sur la biosécurité
Controle efficace de l'importation, l'exportation, le transport , la production des OGM .
Réviser le cadre juridique et institutionnel de prévention des risques biotechnologiques Assurer une utilisation sécurisée des biotechnologies Soutenir un développement endogène des biotechnologies modernes |
Alignment
GBF-G-B. Biodiversity is sustainably used and its contributions to people are maintained, enhanced or restored
GBF-G-C. Benefits from the use of genetic resources are shared and substantially increased
GBF-G-D. The biodiversity funding gap of 700 billion USD is progressively closed by ensuring adequate means of implementation are available.
| Global Targets | Degree of Alignment |
GBF-T17. Strengthen biosafety and distribute benefits of biotechnology GBF-T17. Strengthen biosafety and distribute benefits of biotechnologyEstablish, strengthen capacity for, and implement in all countries biosafety measures as set out in Article 8(g) of the Convention on Biological Diversity and measures for the handling of biotechnology and distribution of its benefits as set out in Article 19 of the Convention. | High |
GBF-T01. All areas are planned or managed to bring loss of areas of high biodiversity importance close to zero GBF-T01. All areas are planned or managed to bring loss of areas of high biodiversity importance close to zeroEnsure that all areas are under participatory, integrated, and biodiversity inclusive spatial planning and/or effective management processes addressing land and sea use change, to bring the loss of areas of high biodiversity importance, including ecosystems of high ecological integrity, close to zero by 2030, while respecting the rights of indigenous peoples and local communities. | Medium |
GBF-T03. 30% of areas are effectively conserved GBF-T03. 30% of areas are effectively conservedEnsure and enable that by 2030 at least 30 per cent of terrestrial, inland water, and of coastal and marine areas, especially areas of particular importance for biodiversity and ecosystem functions and services, are effectively conserved and managed through ecologically representative, well-connected and equitably governed systems of protected areas and other effective area-based conservation measures, recognizing indigenous and traditional territories where applicable, and integrated into wider landscapes, seascapes and the ocean, while ensuring that any sustainable use, where appropriate in such areas, is fully consistent with conservation outcomes, recognizing and respecting the rights of indigenous peoples and local communities, including over their traditional territories. | High |
GBF-T20. Capacity-building and development, technology transfer, and technical and scientific cooperation for implementation is strengthened GBF-T20. Capacity-building and development, technology transfer, and technical and scientific cooperation for implementation is strengthenedStrengthen capacity-building and development, access to and transfer of technology, and promote development of and access to innovation and technical and scientific cooperation, including through South-South, North-South and triangular cooperation, to meet the needs for effective implementation, particularly in developing countries, fostering joint technology development and joint scientific research programmes for the conservation and sustainable use of biodiversity and strengthening scientific research and monitoring capacities, commensurate with the ambition of the goals and targets of the framework. |
Access to financial resources
Biodiversity and health
Cooperation and synergies
Ecosystem approach
Science and innovation
Gender
mise en place d'un comité nationale de biosécurité et harmonisation des textes avec les autres pays.
Indicators to be used to monitor this national target
1.1 Percentage of land and sea area covered by biodiversity-inclusive spatial plans
3.1 Coverage of protected areas and other effective area-based conservation measures
A.1 Red List of Ecosystems
A.2 Extent of natural ecosystems
B.1 Services provided by ecosystems
C.1 Monetary benefits received in accordance with applicable internationally agreed access and benefit-sharing instruments
C.2 Non-monetary benefits arising from applicable international access and benefit-sharing instruments
D.1 International public funding, including official development assistance for conservation and sustainable use of biodiversity and ecosystems
D.2 Domestic public funding on conservation and sustainable use of biodiversity and ecosystems
D.3 Private funding (domestic and international) on conservation and sustainable use of biodiversity and ecosystems
1.b Number of countries using participatory, integrated and biodiversity-inclusive spatial planning and/or effective management processes addressing land- and sea-use change to bring the loss of areas of high biodiversity importance close to zero by 2030
17.b Number of countries that have taken action to implement biosafety measures as set out in Article 8(g) of the Convention and measures for the handling of biotechnology and the distribution of its benefits as set out in Article 19
B.b Number of countries with policies or actions for implementing and monitoring the sustainable use of biodiversity and the maintenance and enhancement of nature’s contributions to people, including ecosystem functions and services
13.b Number of countries that have taken effective legal, policy, administrative and capacity-building measures at all levels, as appropriate, to ensure the fair and equitable sharing of benefits from the utilization of genetic resources and from digital sequence information on genetic resources, as well as traditional knowledge associated with genetic resources
Cadre juridique et intentionnel révisé Les risques avérés ou potentiels liés aux utilisations des biotechnologies sont minimisés. Disponibilité de produits biotechnologiques mis aux points au niveau national Rapport d’évaluation
FR